IVD Can Contribute to t-mAb Effectiveness

Therapeutic monoclonal antibodies are useful therapies but in some cases they work for a period, then lose their effectiveness The role of testing in preventing therapeutic monoclonal antibodies from failing has recently received high-profile attention, with a session at AACC and in other places This blog piece by Kalorama analyst Rob Camp, PhD, looks at the role of testing.


Molecular POC Makes Strides

Molecular POC Makes Strides

Six companies to watch in the development of rapid and small footprint DNA testing near patient.


Record-Breaking Meeting of IVD and Lab Industry Tackles Key Healthcare Issues

Record-Breaking Meeting of IVD and Lab Industry Tackles Key Healthcare Issues

If there's a problem, find a pathologist. And a lab technician and an IVD company for the equipment. That was the implied message of the world's largest meeting of lab professionals as they tackled the largest challenges in healthcare - opioid addiction, healthcare associated infections (HAIs), near-patient results, autism, Alzheimer's, faster test results, better IT. These were all issues discussed at scientific panels and in vendor booths at the meeting. Kalorama Information was on site and noted the developments at the meeting.

  • by Bruce Carlson
  • August 1 2017
  • AACC


"Data Lakes," Yellow Fever, Gene Editing and Middle East Market Among Developments on First Day of AACC 2017

"Data Lakes," Yellow Fever, Gene Editing and Middle East Market Among Developments on First Day of AACC 2017

A quick look at the developments on the first day of The American Association for Clinical Chemistry, and its related Clinical Lab Expo, which brings most of the major IVD vendors out to demonstrate products and discuss new concepts. Already, CRISPR, the Middle East market, Yellow Fever and Order to Report are early developments at the meeting.